It is anticipated that the Global Enzyme Linked Immunosorbent Assay (ELISA) Market will be worth US$ 2,016.1 million in 2022 and is projected to demonstrate a CAGR of 5.1% between 2022 and 2030.
ELISA, short for Enzyme-Linked Immunosorbent Assay, is a type of immunoassay that is utilized to detect a range of substances like peptides, hormones, proteins, and antibodies. It has a broad range of applications in biotechnology and medicine, specifically as a diagnostic tool for detecting target substances in a test sample by observing a change in color and determining their concentration. ELISA is widely used in the diagnosis of Human Immunodeficiency Virus (HIV) infection, pregnancy, and for measuring cytokines, soluble proteins, and other substances. The immunoassay involves various antigen-antibody combinations, which include an enzyme-labeled antigen or antibody, and the enzyme activity is measured.
Request Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/1505
The Global Enzyme Linked Immunosorbent Assay (ELISA) Market is anticipated to experience growth due to a rise in product development activities for ELISA kits.
The global market for Enzyme-Linked Immunosorbent Assay (ELISA) is expected to experience growth due to an increase in product development activities for ELISA kits. As an example, on May 21, 2021, the Defense Institute of Physiology and Allied Sciences (DIPAS), a laboratory of the Defense Research and Development Organization (DRDO), India, collaborated with Vanguard Diagnostics Pvt Ltd to develop an antibody detection-based kit named “’DIPCOVAN”, the DIPAS-VDx COVID-19 IgG Antibody Microwell ELISA, which is designed for sero-surveillance. This kit has the ability to detect both spike and nucleocapsid proteins of the SARS-CoV-2 virus with high sensitivity (97%) and specificity (99%).
Market growth is anticipated to be propelled during the forecast period by the escalation of inorganic activities, such as increased collaboration among market participants.
Market participants are concentrating on expanding their product range and global presence through the implementation of inorganic strategies like partnerships to sustain their market positions. As an example, Syngene International Ltd., a comprehensive research and development services firm, collaborated with HiMedia Laboratories on June 2, 2020. HiMedia Laboratories is a bioscience company with over 45 years of experience in media production and diagnostics. The collaboration aimed to manufacture and distribute ELISA kits, which HiMedia would produce at its Mumbai facility and distribute throughout India.
Impact of the Coronavirus (COVID-19) Pandemic
After the emergence of the COVID-19 virus in December 2019, it quickly spread to more than 100 countries worldwide. On January 30, 2020, the World Health Organization (WHO) declared the disease a public health emergency.
The economy can be impacted by COVID-19 in three primary ways, which include direct effects on clinical diagnostic device production and demand, distribution channel disruptions and financial repercussions on markets and firms. Many nations, including India, Egypt, Saudi Arabia, China, the U.A.E., and others, are encountering transportation difficulties due to nationwide lockdowns, making it challenging to transport clinical diagnostic devices between locations.
The global Enzyme-Linked Immunosorbent Assay (ELISA) market experienced a beneficial effect from the COVID-19 pandemic as regulatory authorities authorized the emergency use of ELISA kits for detecting COVID-19 infection. An example of this is the approval granted by the Central Drugs Standard Control Organization (CDSCO) in India on January 8, 2021, for an ELISA kit produced by CPC Diagnostics Pvt. Ltd., a manufacturer of medical laboratory equipment and analyzer products, specifically designed for the detection of COVID-19 infection.
Market Restraints:
The global Enzyme Linked Immunosorbent Assay (ELISA) market is anticipated to face growth hindrances during the forecast period due to regulatory authorities mandating product recalls. An example of this occurred on December 1, 2020, when the US Food and Drug Administration (FDA) instructed a recall of the ACCEL ELISA COVID19 Test, a Class 2 Device manufactured by VEO Diagnostics, a company specializing in medical diagnostic products, which is utilized for detecting total antibodies to SARS-CoV-2.
Competitive landscape
Key participants, consisting of Shenzhen YHLO Biotech Co., Ltd., R&D Systems, Biomerieux S.A., Bio-Rad Laboratories, Inc., Creative Diagnostics, Enzo Life Sciences, Inc., Alpco, BioLegand, Inc., Zeus Scientific, Inc., and Thermo Fisher Scientific, are operating in the global Enzyme-Linked Immunosorbent Assay (ELISA) market.
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/1505
Market Segmentation:
- Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Method:
- Direct ELISA
- Indirect ELISA
- Sandwich ELISA
- Competitive ELISA
- Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Application:
- Vaccine Development
- Immunology
- Diagnostics
- Toxicology
- Drug Monitoring & Pharmaceutical Industry
- Transplantation
- Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Technology:
- Chemiluminescent
- Colorimetric
- Fluorescent
Recent Development:
Cipla Limited, a pharmaceutical company, declared on October 28, 2020, that it had partnered with KARWA Ltd., a manufacturing and distribution company, to commercialize antibody detection kits for COVID-19 in India. The Indian Council of Medical Research (ICMR) provided the necessary technological expertise and processes to approved manufacturers, including KARWA Ltd., which would manufacture the SARS CoV-2-IgG antibody detection ELISA. As part of the collaboration, Cipla Limited would take care of marketing and distributing the test kits.
Reason to Buy this Report:
■ Analysis of the impact of technological advancements on the market and the emerging trends shaping the industry in the coming years.
■ Examination of the regulatory and policy changes affecting the market and the implications of these changes for market participants.
■ Overview of the competitive landscape in the Enzyme Linked Immunosorbent Assay market, including profiles of the key players, their market share, and strategies for growth.
■ Identification of the major challenges facing the market, such as supply chain disruptions, environmental concerns, and changing consumer preferences, and analysis of how these challenges will affect market growth.
■ Evaluation of the potential of new products and applications in the market, and analysis of the investment opportunities for market participants.
Table of Contents with Major Points:
Executive Summary
- Introduction
- Key Findings
- Recommendations
- Definitions and Assumptions
Executive Summary
Market Overview
- Definition of Enzyme Linked Immunosorbent Assay Market
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Trends and Developments
Key Insights
- Key Emerging Trends
- Key Developments Mergers and Acquisition
- New Product Launches and Collaboration
- Partnership and Joint Venture
- Latest Technological Advancements
- Insights on Regulatory Scenario
- Porters Five Forces Analysis
Qualitative Insights Impact of COVID-19 on Global Enzyme Linked Immunosorbent Assay Market
- Supply Chain Challenges
- Steps taken by Government/Companies to overcome this impact
- Potential opportunities due to COVID-19 outbreak
Conclusion
Appendix
- Data Sources
- Abbreviations
- Disclaimer
TOC Continued…!
Ask Here for Customization Report @ https://www.coherentmarketinsights.com/insight/request-customization/1505
Explore More Report:
Rheumatoid arthritis diagnostic tests market
Diagnostic testing of stds market
Methicillin resistant staphylococcus aureus testing systems market
Infectious disease diagnostics market
Pregnancy testing devices market
Fertility and pregnancy rapid test kits market
𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com